Company Analysis ShockWave Medical, Inc.
1. Summary
Advantages
- The stock's return over the last year (5.91%) is higher than the sector average (-25.51%).
- The company's current efficiency (ROE=22.03%) is higher than the sector average (ROE=9.01%)
Disadvantages
- Price (330.7 $) is higher than fair price (58.14 $)
- Dividends (0%) are below the sector average (0.5467%).
- Current debt level 46.95% has increased over 5 years from 9.79%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| ShockWave Medical, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -20.9% | -1.4% |
| 90 days | 0% | -25.3% | -9.2% |
| 1 year | 5.9% | -25.5% | 8.6% |
SWAV vs Sector: ShockWave Medical, Inc. has outperformed the "Healthcare" sector by 31.42% over the past year.
SWAV vs Market: ShockWave Medical, Inc. has underperformed the market marginally by -2.68% over the past year.
Stable price: SWAV is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SWAV with weekly volatility of 0.1137% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (330.7 $) is higher than the fair price (58.14 $).
Price is higher than fair: The current price (330.7 $) is 82.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (50.2) is lower than that of the sector as a whole (57.09).
P/E vs Market: The company's P/E (50.2) is higher than that of the market as a whole (48.45).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (11.06) is higher than that of the sector as a whole (4.61).
P/BV vs Market: The company's P/BV (11.06) is higher than that of the market as a whole (3.38).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (10.13) is lower than that of the sector as a whole (33.5).
P/S vs Market: The company's P/S indicator (10.13) is lower than that of the market as a whole (10.23).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (44.43) is higher than that of the sector as a whole (-19.46).
EV/Ebitda vs Market: The company's EV/Ebitda (44.43) is higher than that of the market as a whole (15.44).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -64.83% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-64.83%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (38.84%).
5.4. ROE
ROE vs Sector: The company's ROE (22.03%) is higher than that of the sector as a whole (9.01%).
ROE vs Market: The company's ROE (22.03%) is higher than that of the market as a whole (8.97%).
5.5. ROA
ROA vs Sector: The company's ROA (9.4%) is higher than that of the sector as a whole (0.0151%).
ROA vs Market: The company's ROA (9.4%) is higher than that of the market as a whole (6.3%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (10.97%) is higher than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (10.97%) is higher than that of the market as a whole (10.96%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5467%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (4.23%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
